American Century Companies Inc. Boosts Stake in Surgery Partners, Inc. (NASDAQ:SGRY)

American Century Companies Inc. grew its stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 223.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,399,756 shares of the company's stock after buying an additional 967,534 shares during the quarter. American Century Companies Inc. owned 1.10% of Surgery Partners worth $29,633,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. increased its holdings in Surgery Partners by 747.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock valued at $124,000 after buying an additional 3,379 shares during the last quarter. KBC Group NV increased its holdings in shares of Surgery Partners by 66.1% in the 4th quarter. KBC Group NV now owns 3,962 shares of the company's stock valued at $84,000 after acquiring an additional 1,577 shares during the last quarter. MeadowBrook Investment Advisors LLC raised its position in shares of Surgery Partners by 16.6% during the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock worth $218,000 after acquiring an additional 1,460 shares in the last quarter. Empowered Funds LLC purchased a new stake in Surgery Partners during the fourth quarter worth approximately $245,000. Finally, Natixis Advisors LLC boosted its holdings in Surgery Partners by 3.0% in the third quarter. Natixis Advisors LLC now owns 12,828 shares of the company's stock valued at $414,000 after purchasing an additional 376 shares in the last quarter.

Surgery Partners Price Performance

Surgery Partners stock traded up $0.06 during midday trading on Wednesday, reaching $23.54. The company's stock had a trading volume of 463,827 shares, compared to its average volume of 1,074,095. The firm has a market capitalization of $3.00 billion, a PE ratio of -49.04, a P/E/G ratio of 19.21 and a beta of 2.40. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $33.97. The stock's 50 day simple moving average is $24.51 and its 200 day simple moving average is $25.41. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80.

Remove Ads

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating the consensus estimate of $0.38 by $0.01. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm had revenue of $864.40 million during the quarter, compared to analysts' expectations of $828.09 million. On average, equities research analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. JPMorgan Chase & Co. cut their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a report on Tuesday, December 3rd. Bank of America assumed coverage on Surgery Partners in a report on Monday, December 16th. They set a "buy" rating and a $30.00 price objective on the stock. Macquarie reduced their target price on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a report on Tuesday, March 11th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $35.00 price target on shares of Surgery Partners in a research report on Tuesday, March 25th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $36.63.

Insider Transactions at Surgery Partners

In other Surgery Partners news, CFO David T. Doherty sold 13,641 shares of the business's stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.61, for a total transaction of $349,346.01. Following the sale, the chief financial officer now directly owns 108,862 shares in the company, valued at approximately $2,787,955.82. The trade was a 11.14 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Harrison R. Bane sold 56,315 shares of the company's stock in a transaction on Friday, February 7th. The shares were sold at an average price of $25.64, for a total value of $1,443,916.60. Following the completion of the sale, the insider now directly owns 107,037 shares in the company, valued at $2,744,428.68. This trade represents a 34.47 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 106,622 shares of company stock valued at $2,717,860 in the last quarter. 2.30% of the stock is currently owned by corporate insiders.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.